date,title,source
Oct-24-18,Myovant Sciences Announces Completion of Enrollment in Phase 3 HERO Trial of Relugolix in Men with Advanced Prostate Cancer,PR Newswire
Nov-07-18,Myovant Strengthens Management Team and Adds New Directors to the Board,PR Newswire
Nov-08-18,"Myovant Provides Corporate Updates and Reports Financial Results for Second Fiscal Quarter Ended September 30, 2018",PR Newswire
Nov-14-18,"Recent Analysis Shows Atlas Financial, Royal Dutch Shell, Vaalco Energy, Myovant Sciences, Aerpio Pharmaceuticals, and Wheeler Real Estate Investment Trust Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
